Abstracts The coronavirus disease 2019 (COVID-19) affects infected patients even after the
acute phase and impairs their health and quality of life by causing a wide variety of …

Coronavirus disease 2019 (COVID-19) is a highly heterogeneous disease regarding
severity, vulnerability to infection due to comorbidities, and treatment approaches. The …

SARS-CoV-2 causes the complex and heterogeneous illness known as COVID-19. The
disease primarily affects the respiratory system but can quickly become systemic, harming …

Coronavirus disease 2019 (COVID‐19) has various manifestations on different body organs,
including the lungs, heart, kidneys, and central nervous system. However, the frequency of …

There is some indication that coronavirus disease 2019 (COVID‐19) causes hypothalamic‐
pituitary‐adrenal axis insufficiency. However, being on glucocorticoids makes it difficult to …

Introduction: There is emerging speculation that the inflammatory state associated with
SARS-CoV-2 infection may trigger autoimmune conditions, but no causal link is established …

Sepsis is associated with dysregulated cortisol secretion, leading to abnormal levels of
cortisol in the blood. In the early stages of the condition, cortisol levels are typically elevated …

Our research has shown that little progress has been made regarding our knowledge on AI.
Coronavirus disease 2019 and ICIs use constitute new evidence on the pathogenesis of AI …

For 2.5 years we have been facing the coronavirus disease (COVID-19) and its health,
social and economic effects. One of its known consequences is the development of …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can
invade both the peripheral and central nervous systems and impact the function of the brain …